Case Report
Published on 31 Jul 2024
Application of eculizumab, a terminal complement inhibitor, in the management of atypical hemolytic uremic syndrome in a 14-month-old Chinese pediatric patient: a case report
in Obstetric and Pediatric Pharmacology
![Application of eculizumab, a terminal complement inhibitor, in the management of atypical hemolytic uremic syndrome in a 14-month-old Chinese pediatric patient: a case report](https://www.frontiersin.org/files/myhome article library/1404725/1404725_Thumb_400.jpg)